3Vote!
Jim Cramer's Mad Money (Free subscription) | 07/17/2008
Jim Cramer’s Mad Money Stock Picks for Wednesday July 16 2008. These are all of Jim Cramer’s stock picks that are a Buy! I bold my picks. Buy: American Superconductor (AMSC) Carnival Corp (CCL) Chesapeake Energy (CHK) CSX Corp (CSX) Gen Probe (GPRO) MDU Resources Group (MDU) Suncor Energy (SU) VF Corp (VFC) Western Gas Partners (WES) Yum! Brands (YUM) Sell: Ambac Financial Group (ABK) Domino’s Pizza...
+Vote!
Eurekalert (Free subscription) | 07/14/2008
( American Society for Microbiology ) The 2008 American Society for Microbiology Gen-Probe Joseph Award is being presented to Bala Swaminathan, vice president, technical and business development, IHRC, Inc., Atlanta, Ga. This award recognizes a distinguished microbiologist who has exhibited exemplary leadership and service in the field of public health.
+Vote!
The Earth Times Online Newspaper (Free subscription) | 07/11/2008
SAN DIEGO, July 10 -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will release its second quarter 2008 financial results on Thursday, July 31, 2008 at approximately 4:00 p.m. Eastern Time...
+Vote!
PR News Wire (Free subscription) | 07/11/2008
SAN DIEGO, July 10 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated
(Nasdaq: ) announced today that the Company will release its second
quarter 2008 financial results on Thursday, July 31, 2008 at approximately
4:00 p.m. Eastern Time (ET). The announcement will be followed by a
conference call at 4:30 p.m. ET. Hank Nordhoff, chairman and chief
executive officer, and Herm Rosenman, senior vice president,...
+Vote!
San Diego Union (Free subscription) | 07/10/2008
San Diego medical diagnostics giant Gen-Probe declined yesterday to increase its June 3 offer for a Belgian biotechnology company after a European rival topped its $297 million bid with a higher offer.
+Vote!
Fiercebiotech (Free subscription) | 07/09/2008
It looks like Solvay, not Gen-Probe , will be buying Belgium's Innogenetics. Back in April Solvay made a $278.2 million (€177.6 million) takeover bid for the company, but San Diego-based Gen-Probe trumped that offer, pledging $334 million for Innogenetics. That meant Innogenetics would get $9.58 per share, but Solvay has now offered $10.22. Gen-Probe won't pursue the deal, saying that a higher offer...
+Vote!
Red Orbit (Free subscription) | 07/09/2008
SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated announced today that the Company does not intend to increase the value of its conditional tender offer to acquire 100% of the outstanding shares, warrants and convertible bonds of Innogenetics (EBR: INNX), a Belgian molecular diagnostics company.
+Vote!
Market Watch (Free subscription) | 07/09/2008
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
+Vote!
The Minneapolis/St. Paul Business Journal (Free subscription) | 06/17/2008
3M Co. is scrapping plans to jointly develop medical products with a California firm, saying the companies' technologies are incompatible. (MMM)
+Vote!
Red Orbit (Free subscription) | 06/17/2008
ST. PAUL, Minn. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- 3M and Gen-Probe Incorporated announced today that 3M has discontinued the companies' collaboration to develop rapid molecular tests for healthcare-associated infections (HCAIs).
1Vote!
PR News Wire (Free subscription) | 06/06/2008
SAN DIEGO, June 6 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated
(Nasdaq: ) announced today that the Company will present at the seventh
annual Needham & Company, LLC, Biotechnology and Medical Technology
Conference on Wednesday, June 11, 2008 at approximately 11 a.m. Eastern
Time (8 a.m. Pacific Time). The presentation is scheduled to be webcast
live and may be accessed through a link on the investor...
1Vote!
San Diego Union (Free subscription) | 06/04/2008
San Diego medical diagnostics giant Gen-Probe said yesterday that it has offered to pay roughly $334 million in cash for a Belgian biotechnology company, topping a friendly buyout offer made 40 days ago.
1Vote!
Red Orbit (Free subscription) | 06/04/2008
WELLESLEY, Mass., June 3 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, has granted Gen-Probe Incorporated and its affiliates a non-exclusive license to use Xceed's novel Flow-Thru Chip technology.
